Pharmacogenetic considerations in the treatment of co-infections with HIV/AIDS, tuberculosis and malaria in Congolese populations of Central Africa-Reference-Cited by-同舟云学术

Pharmacogenetic considerations in the treatment of co-infections with HIV/AIDS, tuberculosis and malaria in Congolese populations of Central Africa

Published:2021-03 Issue: Volume:104 Page:207-213
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Pallerla Srinivas Reddy,Elion Assiana Darrel Ornelle,Linh Le Thi Kieu,Cho Frederick Nchang^ORCID,Meyer Christian G.^ORCID,Fagbemi Kaossarath Adédjokè,Adegnika Ayola Akim,Beng Véronique Penlap,Achidi Eric A.,Kahunu Gauthier Mesia,Bates Mathew^ORCID,Grobusch Martin P.,Kremsner Peter G.,Ntoumi Francine,Velavan Thirumalaisamy P.^ORCID

Funder

European and Developing Countries Clinical Trials Partnership

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference71 articles.

1. Factors affecting the development of adverse drug reactions (Review article);Alomar;Saudi Pharm J,2014

2. African variation at Cytochrome P450 genes: evolutionary aspects and the implications for the treatment of infectious diseases;Bains;Evol Med Public Health,2013

3. Impact of comorbidity on adverse drug reaction profile in a cohort of patients treated with Artemisinin combination therapies for uncomplicated malaria in Nigeria;Bassi;Pharmacol Res Perspect,2017

4. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis;Ben Mahmoud;Pathol Biol (Paris),2012

5. Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria;Bennett;N Engl J Med,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced hepatotoxicity and association with slow acetylation variants NAT2*5 and NAT2*6 in Cameroonian patients with tuberculosis and HIV co-infection;BMC Infectious Diseases;2024-07-31

2. Towards pharmacogenomics-guided tuberculosis (TB) therapy: N-acetyltransferase-2 genotypes among TB-infected Kenyans of mixed ethnicity;BMC Medical Genomics;2024-01-06

3. The Impact of Certain Pharmacogenetic Differences on the Metabolism of Antiretroviral Drugs Used in A Black South African Population;Current Drug Metabolism;2023-10

4. Host genetic loci LZTFL1 and CCL2 associated with SARS-CoV-2 infection and severity of COVID-19;International Journal of Infectious Diseases;2022-09

5. An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria;Expert Opinion on Drug Metabolism & Toxicology;2022-01-02